GRASSI, GUIDO
 Distribuzione geografica
Continente #
NA - Nord America 63.189
EU - Europa 23.900
AS - Asia 12.114
SA - Sud America 242
AF - Africa 112
OC - Oceania 69
Continente sconosciuto - Info sul continente non disponibili 62
Totale 99.688
Nazione #
US - Stati Uniti d'America 62.180
CN - Cina 4.386
SG - Singapore 4.088
SE - Svezia 3.928
IE - Irlanda 3.755
IT - Italia 3.403
RU - Federazione Russa 3.319
DE - Germania 3.308
UA - Ucraina 2.515
HK - Hong Kong 1.929
GB - Regno Unito 1.240
CA - Canada 916
FI - Finlandia 740
VN - Vietnam 449
FR - Francia 409
AT - Austria 327
IN - India 307
ID - Indonesia 306
TR - Turchia 225
NL - Olanda 200
DK - Danimarca 174
BR - Brasile 125
BE - Belgio 105
JP - Giappone 84
PL - Polonia 72
MX - Messico 69
CZ - Repubblica Ceca 66
IR - Iran 64
AU - Australia 57
EU - Europa 50
ES - Italia 48
KR - Corea 48
RO - Romania 48
TW - Taiwan 44
GR - Grecia 41
PT - Portogallo 34
CH - Svizzera 28
PH - Filippine 28
CL - Cile 26
BG - Bulgaria 22
PK - Pakistan 21
AR - Argentina 20
PE - Perù 20
VE - Venezuela 20
EG - Egitto 17
NG - Nigeria 17
TH - Thailandia 17
ZA - Sudafrica 16
CO - Colombia 15
MY - Malesia 15
SK - Slovacchia (Repubblica Slovacca) 15
HU - Ungheria 14
LT - Lituania 14
NO - Norvegia 13
EC - Ecuador 12
IQ - Iraq 12
MU - Mauritius 12
NZ - Nuova Zelanda 12
LV - Lettonia 11
A2 - ???statistics.table.value.countryCode.A2??? 10
AE - Emirati Arabi Uniti 10
LK - Sri Lanka 10
RS - Serbia 10
SA - Arabia Saudita 10
TN - Tunisia 9
KE - Kenya 8
BD - Bangladesh 7
MK - Macedonia 7
AL - Albania 6
BY - Bielorussia 6
CM - Camerun 6
KG - Kirghizistan 6
KZ - Kazakistan 6
BJ - Benin 5
DZ - Algeria 5
IL - Israele 5
LB - Libano 5
MA - Marocco 5
MD - Moldavia 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
DO - Repubblica Dominicana 4
EE - Estonia 4
UZ - Uzbekistan 4
BH - Bahrain 3
HR - Croazia 3
MN - Mongolia 3
NP - Nepal 3
PR - Porto Rico 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
YE - Yemen 3
AZ - Azerbaigian 2
BB - Barbados 2
BZ - Belize 2
GD - Grenada 2
GE - Georgia 2
GY - Guiana 2
JO - Giordania 2
KH - Cambogia 2
Totale 99.657
Città #
Ann Arbor 12.308
Fairfield 6.263
Woodbridge 6.101
Houston 4.545
Dublin 3.584
Singapore 3.384
Chandler 3.314
Ashburn 2.961
Wilmington 2.850
Jacksonville 2.827
Seattle 2.541
Frankfurt am Main 2.175
Dearborn 2.031
Cambridge 2.011
Hong Kong 1.895
Princeton 1.646
New York 1.560
Santa Clara 1.145
Milan 976
Lawrence 778
Altamura 723
Nanjing 688
Beijing 647
Lachine 459
San Diego 420
Shanghai 415
Hangzhou 409
Vienna 304
Jakarta 283
Andover 277
Boardman 245
Nanchang 240
Helsinki 232
Guangzhou 206
Shenyang 199
Toronto 197
Hebei 191
Dong Ket 189
Ottawa 173
Tianjin 146
Jiaxing 137
Falls Church 136
Changsha 134
London 129
Norwalk 123
Jinan 114
Lissone 112
Fremont 108
Brussels 88
Rome 84
Los Angeles 77
Mountain View 75
Kunming 74
Ningbo 67
Huizen 65
San Mateo 63
Zhengzhou 62
Chicago 56
Pune 56
Munich 55
Brno 54
Redmond 51
Washington 50
Philadelphia 47
Hefei 46
Monza 46
Nürnberg 46
Lappeenranta 44
São Paulo 43
Dallas 42
Detroit 39
Istanbul 39
University Park 34
Edmonton 33
Cinisello Balsamo 31
Moscow 31
Sacramento 31
Fuzhou 30
Taizhou 30
Auburn Hills 29
Carate Brianza 27
Kiev 27
Leawood 25
Amsterdam 24
Taiyuan 24
Kraków 23
Monmouth Junction 23
Hounslow 22
Wuhan 22
Bologna 21
Hyderabad 21
Laurel 21
Naples 20
Phoenix 20
Groningen 19
Esslingen am Neckar 18
Kilburn 18
Lanzhou 18
Lima 18
Taipei 18
Totale 74.578
Nome #
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) 736
'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: Morphological criteria and clinical impact 372
Heart rate as a sympathetic marker during acute adrenergic challenge 305
Big data, observational research and P-value: a recipe for false-positive findings? A study of simulated and real prospective cohorts 302
Sex-related relationships between uric acid and target organ damage in hypertension 299
Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid 298
Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects 288
Hemodynamic effects of acute and prolonged administration of nitrendipine in essential hypertension 282
Calcium antagonists and neural control of circulation in essential hypertension 270
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 261
Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate 258
Cardiopulmonary receptor regulation of renin release 257
Early alterations in left ventricular diastolic function in normotensive diabetic patients 253
Cardiovascular Remodeling after Endovascular Treatment for Thoracic Aortic Injury 251
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 246
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified 245
Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension 241
Prognostic significance of masked tachycardia in hypertension: Evidence from a prospective international registry 240
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 239
In healthy normotensive subjects age and blood pressure better predict subclinical vascular and cardiac organ damage than atherosclerosis biomarkers 236
Heart rate as cardiovascular risk factor 235
A case of Pseudomonas Aeruginosa commercial tattoo infection 231
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 231
The effects of sex and method of blood pressure measurement on genetic associations with blood pressure in the PAMELA study 229
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension 228
Association Between Atrial, Ventricular and Vascular Morphofunctional Alterations in Rheumatoid Arthritis 222
Blood pressure and heart rate variabilities in normotensive and hypertensive human beings 216
Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol 215
Predictors of pwv progression over a three years follow up: focus on psychological characteristics 214
Effects of ageing on the cardiopulmonary receptor reflex in normotensive humans 212
Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach 210
Influence of cardiopulmonary receptors on the bradycardiac responses to carotid baroreceptor stimulation in man 209
Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage 209
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people 208
Blood pressure response to labetalol in twice and three times daily administration during a 24‐hour period 208
Differing associations for sport versus occupational physical activity and cardiovascular risk 208
2007 ESH-ESC guidelines for the management of arterial hypertension - The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC) 207
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 205
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 204
Evaluation of a slow-release clonidine preparation by direct continuous blood pressure recording in essential hypertensive patients 203
Mechanisms of antihypertensive action of beta-adrenergic blocking drugs: evidence against potentiation of baroreflexes 202
Psychological Predictors of Arterial Stiffness Progression over a Three Years Follow Up 202
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 201
Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol 201
Two-Drug Combinations as First-Step Antihypertensive Treatment 201
Modification of arterial baroreflexes by captopril in essential hypertension 200
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 199
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 197
Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up 196
Vitamin B12 deficiency-induced pseudothrombotic microangiopathy without macrocytosis presenting with acute renal failure: a case report 196
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms 193
Baroreflex and non-baroreflex modulation of vagal cardiac control after myocardial infarction 193
Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension 192
High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population 192
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome 191
Control of circulation by arterial baroreceptors and cardiopulmonary receptors in hypertension 191
Cardiovascular risk factor profile in an italian cohort of patients with rheumatoid arthritis: results of a three years follow-up 191
Structural alterations of the retinal microcirculation in the "prehypertensive" high- normal blood pressure state 190
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 190
Left atrial volume in elite athletes: A meta-analysis of echocardiographic studies 190
The Pamela study: main findings and perspectives 189
Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse: A case report 189
Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis 189
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 189
Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure 188
Cardiogenic reflexes and left ventricular hypertrophy 188
[Are plasma catecholamine levels capable of reflecting even small variations in sympathetic activity?] 188
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 188
It is never too late for a genetic disease: a case of a 79-year-old man with persistent hypokalemia 187
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 186
Treatment of hypertension: The ESH/ESC guidelines recommendations 186
Alerting reaction and rise in blood pressure during measurement by physician and nurse 186
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 185
The impact of arterial hypertension on left ventricular strain in patients with aortic stenosis and preserved ejection fraction. 185
Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis 185
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 184
Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease 183
Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study 183
Iron Overload Increases Sympathetic Nervous Activity: Study in Hemochromatosis Patients at Diagnosis and Iron Depletion 183
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites 182
Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study 182
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study 181
Similarities and differences between renal sympathetic denervation and carotid baroreceptor stimulation 180
Statins and the risk of diabetes: Evidence from a large population-based cohort study 179
Adrenergic and reflex abnormalities in obesity-related hypertension 178
Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child a cirrhosis 177
Body fat mass is a strong and negative predictor of peak stimulated growth hormone and bone mineral density in healthy adolescents during transition period 177
[Direct and continuous recording of arterial pressure in the diagnosis of pheochromocytoma] 177
The association between 24-h blood pressure patterns and left ventricular mechanics 177
Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis 177
Multiple sampling improves norepinephrine reproducibility in essential hypertension: a comparison with the microneurographic technique 176
Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartan 176
Blood pressure control in hypertension. Pros and cons of available treatment strategies 175
Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity 174
Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis. 174
Cardiopulmonary receptor reflex in hypertension 174
Cardiac and vascular structural changes in normotensive subjects with parental hypertension 174
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: Rationale for further study on blood pressure targets of antihypertensive treatment after stroke 174
Limited reproducibility of MUCH and WUCH: Evidence from the ELSA study 174
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 174
Totale 21.344
Categoria #
all - tutte 388.978
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 388.978


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209.755 0 0 0 0 0 2.188 2.273 1.347 1.688 821 1.021 417
2020/202114.875 987 810 1.289 1.399 1.077 1.379 1.737 1.478 1.203 1.537 784 1.195
2021/202210.935 791 951 1.293 930 814 744 526 679 638 762 978 1.829
2022/202314.314 2.112 4.076 1.131 1.153 862 2.360 194 817 889 109 400 211
2023/202411.472 322 293 482 532 1.772 2.742 2.129 325 1.204 226 212 1.233
2024/202511.733 1.760 3.941 1.278 1.366 2.575 813 0 0 0 0 0 0
Totale 102.986